A carregar...
Rituximab in the treatment of non-Hodgkin’s lymphoma
Besides traditional cytostatic drugs the introduction of monoclonal antibodies has substantially influenced current treatment concepts of non-Hodgkin’s lymphoma (NHL). Rituximab, a monoclonal anti-CD20 chimeric antibody, now has been widely evaluated in the various B-cell lymphatic neoplasms. Large...
Na minha lista:
Main Authors: | , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Dove Medical Press
2008
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2727901/ https://ncbi.nlm.nih.gov/pubmed/19707443 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|